Showing results (541-550 of 561) with videos related to

Sort By:
Pageof 57
Cell|August 27, 2025
Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancersEmily Grist, Peter Dutey-Magni, Marina A Parry, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2018
Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium StudyKiri A Sandler, Ryan R Cook, Jay P Ciezki, et al.
JAMA Oncology|October 22, 2020
Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the ProstateRobert T Dess, Krithika Suresh, Michael J Zelefsky, et al.
JAMA|March 7, 2018
Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate CancerAmar U Kishan, Ryan R Cook, Jay P Ciezki, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 2022
External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium AnalysisSagar A Patel, Ting Martin Ma, Jessica K Wong, et al.
European Urology|April 18, 2019
Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective AnalysisKiri A Sandler, Ryan R Cook, Jay P Ciezki, et al.
Research Square|February 17, 2023
Clinical testing of transcriptome-wide expression profiles in high-risk localized and metastatic prostate cancer starting androgen deprivation therapy: an ancillary study of the STAMPEDE abiraterone Phase 3 trialMarina A Parry, Emily Grist, Larissa Mendes, et al.
Prostate Cancer and Prostatic Diseases|May 28, 2026
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progressionFabio Turco, Silke Gillessen, Giuseppe Salfi, et al.
JAMA Oncology|November 20, 2025
Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer: A Meta-AnalysisNicholas G Zaorsky, Yilun Sun, Abdenour Nabid, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 11, 2025
oDigital pathology biomarkers for guiding radiotherapy-based treatment concepts in prostate cancer - a systematic review and expert consensusConstantinos Zamboglou, William De Doncker, Andreas Thomas Christoforou, et al.
Pageof 57